H. Deguchi

发表

Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide

J. Griffin, S. Middeldorp, H. Deguchi, 2005, Journal of thrombosis and haemostasis : JTH.

Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis

E. Gabazza, H. Shiku, H. Wada, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Increased plasma‐soluble fibrin monomer levels in patients with disseminated intravascular coagulation

H. Shiku, H. Wada, H. Deguchi, 1996, American journal of hematology.

Cardiolipin is a normal component of human plasma lipoproteins.

José A Fernández, J. Griffin, J. A. Fernandez, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of thrombin generation in human plasma by phospholipid transfer protein

José A Fernández, J. Griffin, J. Albers, 2015, Thrombosis Journal.

Re-Evaluation of the Anticoagulant Properties of High-Density Lipoprotein—Brief Report

José A Fernández, J. Griffin, J. Witztum, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

J. Griffin, S. Marcovina, H. Kennedy, 2010, Clinica chimica acta; international journal of clinical chemistry.

Sphingolipids as Bioactive Regulators of Thrombin Generation*

J. Griffin, H. Deguchi, S. Yegneswaran, 2004, Journal of Biological Chemistry.

Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.

H. Deguchi, M. Tsuda, S. Shirakawa, 1994, Internal medicine.

Cholesterol enhances phospholipid‐dependent activated protein C anticoagulant activity

J. Griffin, H. Deguchi, N. Pecheniuk, 2005, Journal of thrombosis and haemostasis : JTH.

Elevated plasma fibronectin levels associated with venous thromboembolism

J. Griffin, H. Deguchi, D. Elias, 2008, Thrombosis and Haemostasis.

Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk

J. Griffin, H. Deguchi, D. Elias, 2017, Research and practice in thrombosis and haemostasis.

Is adiponectin implicated in venous thromboembolism?

J. Griffin, J. A. Fernandez, H. Deguchi, 2006, Journal of thrombosis and haemostasis : JTH.

Plasma‐activated factor VII level in patients positive for lupus anticoagulant

H. Shiku, H. Wada, H. Deguchi, 1997, American journal of hematology.

Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.

J. Griffin, H. Deguchi, D. Elias, 2020, Thrombosis research.

Towards the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks.

Masahiro Wakao, Y. Suda, A. Mawatari, 2010, Tetrahedron.

Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids

G. Siuzdak, J. Griffin, S. Trauger, 2014, British journal of haematology.

Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin

J. Griffin, H. Deguchi, Shravan Morla, 2020, Journal of thrombosis and haemostasis : JTH.

Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo

O. McCarty, J. Griffin, T. Eckle, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males Short Title: CETP genotype associated with venous thrombosis

J. Griffin, H. Deguchi, D. Elias, 2011 .

Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males

J. Griffin, H. Deguchi, D. Elias, 2006, Journal of thrombosis and haemostasis : JTH.

Variation in Human Platelet Glycoprotein VI Content Modulates Glycoprotein VI–Specific Prothrombinase Activity

T. Kunicki, H. Deguchi, K. Clemetson, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Adenosine regulates tissue factor expression on endothelial cells.

E. Gabazza, H. Deguchi, K. Suzuki, 1998, Thrombosis research.

Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex

José A Fernández, J. Griffin, Yajnavalka Banerjee, 2015, PloS one.

Molecular interaction site on procoagulant myosin for factor Xa–dependent prothrombin activation

J. Griffin, H. Deguchi, Weijun Shen, 2019, The Journal of Biological Chemistry.

Neutral Glycosphingolipid-dependent Inactivation of Coagulation Factor Va by Activated Protein C and Protein S*

José A Fernández, J. Griffin, H. Deguchi, 2002, The Journal of Biological Chemistry.

Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

José A Fernández, J. Griffin, J. Albers, 2009, Biochimica et biophysica acta.

Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.

José A Fernández, J. Griffin, J. A. Fernandez, 2001, Blood.

Causes of Thrombophilia Yet to Be Discovered: A Personal View

José A Fernández, J. Griffin, H. Deguchi, 2001, Pathophysiology of Haemostasis and Thrombosis.

Glucosylceramide, a Neutral Glycosphingolipid Anticoagulant Cofactor, Enhances the Interaction of Human- and Bovine-activated Protein C with Negatively Charged Phospholipid Vesicles*

J. Griffin, H. Deguchi, S. Yegneswaran, 2003, The Journal of Biological Chemistry.

Hemorrhagic shock and tissue injury provoke distinct components of trauma-induced coagulopathy in a swine model

A. Sauaia, J. Griffin, C. Silliman, 2022, European Journal of Trauma and Emergency Surgery.

Gain in translation: heme oxygenase‐1 induced by activated protein C promotes thrombus resolution

J. Griffin, H. Deguchi, D. Elias, 2014, Journal of thrombosis and haemostasis : JTH.

Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients

José A Fernández, J. Griffin, H. Deguchi, 2019, Research and practice in thrombosis and haemostasis.

Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes.

E. Gabazza, Koji Suzuki, H. Wada, 1997, Blood.

Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin

José A Fernández, J. Griffin, H. Deguchi, 2019, Haematologica.

Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.

T. Koike, E. Gabazza, E. Matsuura, 1997, The Journal of clinical investigation.

Plasma cholesteryl ester transfer protein and blood coagulability

José A Fernández, J. Griffin, H. Deguchi, 2007, Thrombosis and Haemostasis.

Anti – b 2-Glycoprotein I ( b 2 GPI ) Monoclonal Antibodies with Lupus Anticoagulant-like Activity Enhance the b 2 GPI Binding to Phospholipids

T. Koike, E. Gabazza, Koji Suzuki, 2013 .

2GPI) Monoclonal Antibodies with Lupus Anticoagulant-like Activity Enhance the b 2GPI Binding to Phospholipids

T. Koike, E. Gabazza, Koji Suzuki, 1997 .

Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin‐dependent anticoagulant activity

J. Griffin, H. Deguchi, Shravan Morla, 2020, Journal of thrombosis and haemostasis : JTH.

Endothelial and antithrombotic actions of HDL.

J. Griffin, C. Mineo, P. Shaul, 2006, Circulation research.

Full‐length plasma skeletal muscle myosin isoform deficiency is associated with coagulopathy in acutely injured patients

M. Cohen, J. Griffin, H. Deguchi, 2022, Journal of thrombosis and haemostasis : JTH.

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases

N. Dowling, J. Griffin, F. España, 2017, Research and practice in thrombosis and haemostasis.

Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

E. Gabazza, H. Shiku, H. Wada, 1999, American journal of hematology.

Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation

O. McCarty, J. Griffin, A. Gruber, 2022, The Journal of biological chemistry.

A Chimeric Mouse Model of Gaucher Disease

B. Torbett, E. Beutler, C. West, 2002, Molecular medicine.

Novel exomic rare variants associated with venous thrombosis

A. Torkamani, J. Griffin, H. Deguchi, 2020, British journal of haematology.

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.

José A Fernández, G. Siuzdak, J. Griffin, 2015, Blood.

Arteriovenous Blood Metabolomics: A Readout of Intra-Tissue Metabostasis

Caroline H. Johnson, G. Siuzdak, Mohit M. Jain, 2015, Scientific Reports.

Protein C activation in NIDDM patients

M. Sata, K. Murata, J. Nishioka, 1996, Diabetologia.

Plasma Lipoproteins, Hemostasis and Thrombosis

José A Fernández, J. Griffin, J H Griffin, 2001, Thrombosis and Haemostasis.

Increased plasma levels of tissue factor pathway inhibitor‐activated factor X complex in patients with disseminated intravascular coagulation

E. Gabazza, H. Shiku, Y. Okugawa, 2000, American journal of hematology.

Prothrombin and Its Derivatives Stimulate Motility of Melanoma Cells

E. Gabazza, Koji Suzuki, Hong Zhou, 1998, Thrombosis and Haemostasis.

High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men

J. Griffin, H. Deguchi, D. Elias, 2005, Circulation.

Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism

J. Griffin, Yajnavalka Banerjee, H. Deguchi, 2016, Journal of atherosclerosis and thrombosis.

Acquired Activated Protein C Resistance in Patients with Lupus Anticoagulant and Essential Thrombocythemia

J. Nishioka, E. Gabazza, Koji Suzuki, 1997 .

The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis

José A Fernández, J. Björkegren, J. Hansen, 2011, Journal of lipids.

Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation

E. Gabazza, H. Shiku, Y. Okugawa, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells

Hiroshi Deguchi, John H. Griffin, José A Fernández, 2009, Proceedings of the National Academy of Sciences.

Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

O. McCarty, M. Cohen, J. Griffin, 2016, Blood.

Elevated serum amyloid A is associated with venous thromboembolism

J. Griffin, F. España, H. Deguchi, 2012, Thrombosis and Haemostasis.

Striated muscle myosin and blood coagulation

H. Deguchi, Taichi K Deguchi, 2020, Japanese Journal of Thrombosis and Hemostasis.

Cardiac and Skeletal Muscle Myosin Exert Procoagulant Effects.

A. Sauaia, E. Moore, M. Cohen, 2019, Shock.

Rapid Communication: Cardiac and Skeletal Muscle Myosin Exert Procoagulant Effects.

A. Sauaia, E. Moore, M. Cohen, 2019, Shock.